$HNGE News

Hinge Health (HNGE) Price Target Increased by 20.86% to 70.92

Hinge Health, Inc. 2026 Q1 - Results - Earnings Call Presentation

Canaccord Genuity Maintains Buy on Hinge Health, Raises Price Target to $63

Stifel Maintains Buy on Hinge Health, Raises Price Target to $67

RBC Capital Maintains Outperform on Hinge Health, Raises Price Target to $65

Barclays Maintains Overweight on Hinge Health, Raises Price Target to $62

Citizens Maintains Market Outperform on Hinge Health, Raises Price Target to $80

Wells Fargo Maintains Overweight on Hinge Health, Raises Price Target to $80

Needham Maintains Buy on Hinge Health, Raises Price Target to $63

Hinge Health, Inc. (HNGE) Q1 2026 Earnings Call Transcript

Hinge Health (NYSE:HNGE) Q1 Blowout: Revenue and Earnings Surge Past Estimates, Lifting Outlook

Hinge Health Raises FY2026 Sales Guidance from $732.000M-$742.000M to $798.000M-$804.000M vs $735.921M Est

Hinge Health Sees Q2 Sales $194.000M-$196.000M vs $179.019M Est

Hinge Health Q1 Adj. EPS $0.45 Beats $0.38 Estimate, Sales $182.307M Beat $172.164M Estimate

Evercore ISI Group Maintains Outperform on Hinge Health, Lowers Price Target to $45

RBC Capital Maintains Outperform on Hinge Health, Raises Price Target to $55

Hinge Health: More Immune To AI Than Most; A Fast-Growing, Highly Cash-Flowing Market Leader

Hinge Health (HNGE) Climbs 17% on Revenue Jump, Double-Digit Growth Hopes

3 Growth Companies Insiders Are Betting On

Sector Update: Health Care Stocks Rise Late Afternoon